Studies on the effect of androgenic steroids on thyroid function are difficult to evaluate because of a number of apparent discrepancies. Money, Kirschner, Kraintz, Merrill, and Rawson (1), using castrate rats on a low iodine diet, found that testosterone propionate had no influence on thyroid weight or on thyroid weight: body weight ratio, but did increase the radioiodine uptake. Kochakian and Evans (2) recently reported that this form of testosterone failed to influence the uptake or release of radioiodine by the thyroid of the castrate rat. Burris, Bogart, and Krueger (3), using heifers and young steers, found that testosterone propionate produced an increased gain in weight; furthermore, the thyroids of the treated animals weighed more, contained less colloid, and exhibited an increase in thyroid cell height. Voitkevich (4) is cited as stating that the goiters produced by propylthiouracil in guinea pigs and cocks are very considerably decreased by simultaneously administered methyl testosterone, and that propylthiouracil goiters are larger in castrate than -in normal cocks.
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In man, Kinsell, Hertz, and Reifenstein (5) demonstrated that tesosterone propionate reversed the negative nitrogen balance and creatinuria of two hyperthyroid patients, although without having clearcut effect on their hypermetabolism. Methyl tesosterone, on the other hand, induced a less sustained positive nitrogen balance, increased the creatinuria, and appeared to exacerbate the hyperthyroidism. Recently, Keitel and Sherer (6) observed that the administration of methyl testosterone to dwarfed children and to adults with metastatic breast carcinoma, produced decreases in the serum protein-bound iodine and in radioio-dine uptake. The present study was undertaken to investigate the mechanism of these effects. Studies in the same subjects of thyroid radioiodine clearance, of thyroxine-binding protein (TBP), and of the rate of degradation of thyroxine, might serve to differentiate direct effects on the thyroid from extrathyroidal mechanisms.
METHODS
The subj ects were three adult males and one prepubescent girl. Pertinent data are included in Table I. The subjects, with the exception of B. B., were hospitalized during the study and were on reasonably constant activity and diet. After a suitable control period, methyl testosterone was given in a dosage of 100 mg. daily (25 mg. four times daily per os) for seven weeks. The times of the studies in relation to duration of treatment are listed in the tables. In vivo counting was done with a collimated scintillation counter having a one-eighth inch lead window and placed at 40 cm. from the suprasternal notch. The collimation was such that the circle seen at 40 cm. which included the 50 per cent maximal counting rate was 12 cm. in diameter. In vitro counting of plasma and urine samples was done in a well-type scintillation counter.
Radiothyroxine disappearance rates, organic iodine pools, and iodine degradation were measured, using the slope and intercept method of calculation (7) . I'-labeled L-thyroxine 2 (5 to 10 micrograms, 50 to 100 microcuries per dose) was given intravenously, and samples of serum were assayed daily for two weeks thereafter. Thyroidal reaccumulation of iodide was blocked with methimazole, 80 mg. daily.
Basal metabolism was measured weekly. Proteinbound iodine (PBI) in serum was measured three times in each period of testing, using the modified method of Barker and Humphrey (8) or a modification of the Zak, Willard, Myers, and Boyle (9) procedure. Thyroxinebinding protein (TBP) of the serum was assayed by the method described earlier (10) and calculation of the free thyroxine level was made using equations evaluated (11) . Iodide clearances were obtained from intravenous radioiodide tracers by measuring the radioactivity over the neck, in heparinized plasma, and in urine at numerous intervals for six hours (12) . To determine the fraction of the neck counts due to extrathyroidal sources, a separate radioiodide tracer was given to each of three of the subjects at the conclusion of the study and after his gland had been "blocked" with 2 grams of sodium iodide. Two grams of sodium iodide is a dose sufficient to dilute the I' so that if as much as 2 or 3 mg. of iodine is accumulated by the thyroid, only approximately 0.1 per cent of the I' will be accumulated. From the curves of neck and plasma radioactivity so obtained, corrections for extrathyroidal activity corresponding to the plasma levels of the initial, unblocked tracer were found. Extrathyroidal neck radioactivity was then calculated on the basis of the level of I' in plasma. Clearances were calculated in the usual manner from two to six hours after the dose of radioiodide.
RESULTS

Clinical changes
None of the patients showed any symptoms or signs of hypo-or hyperthyroidism, and none had any toxic symptoms from the methyl testoterone or Tapazole®. The three patients weighed repeatedly gained 1 to 2 Kg. each during the treatment period, and lost the weight within two weeks after discontinuing the drug. Basal metabolism rates proved to be uninterpretably variable. Serum cholesterol values rose in all patients during treatment and returned toward control levels after the medication was discontinued (Figure 1 ). In the case of D. W., values had not yet returned to pretreatment levels four weeks after treatment had been stopped.
Iodide metabolism
Thyroidal uptake of radioiodide, thyroidal iodide clearance, and renal iodide clearance were measured before methyl testosterone and after 47 to 51 days on the drug (Table II) . All values were within the normal range. Although the data for each of the subjects (except L. W. on testosterone) were internally compatible in that the 24 hour uptake could be reasonably predicted from the corresponding thyroidal and renal clearances, the differences observed between control and treatment values revealed no consistent effect of the drug.
Thyroxine metabolism
The changes in hormonal iodine levels in serum are shown in Table III (11, 13) . No qualitative alteration in the distribution of thyroxine among the serum proteins, as determined The arrows after thyroxine' and I" represent, respectively, the times at which the labeled thyroxine was injected for the turnover studies and the time the iodide tracer studies were done.
vated free thyroxine or as a result of the increased thyroxine metabolism, pituitary secretion of thyrotropic hormone might then be suppressed, resulting in a decrease in the turnover and uptake of iodine by the thyroid gland. The combined effect of increased thyroxine degradation and decreased thyroxine secretion would lead to a fall in serum thyroxine and, ultimately, a new steady state in which the serum PBI is depressed, the free thyroxine level is normal, and thyroid iodide clearance, thyroid hormone secretion, and thyroxine degradation are normal.
In keeping with such a theory, this study revealed an increase in the free thyroxine level in serum, an increase in thyroxine degradation, and a fall in serum PBI in some or all of the subjects. It would appear that a new steady state had not yet been reached after four weeks of testosterone treatment, when TBP and thyroxine disappearance were determined, although after seven weeks it might have been (vide infra).
Several objections to the above interpretation should be considered.
1) The method of calculation of extrathyroidal organic iodine (by intercept), of degradation (by final slope), and of organic iodine degradation rate is at best approximate. Only if there are no changes in diffusion rates is the use of these values valid for comparison, even in the same patient.
2) The errors and assumptions involved in calculation of free thyroxine have been detailed previously and still obtain (11, 14) . A further problem in the present study is the fact that with such low values for thyroxine-binding capacity of TBP, the accuracy of the free thyroxine value is strongly dependent on the precision with which the PBI has been measured. Thus, at low PBI concentrations, variation within the limits of error of the PBI method will produce large changes in the calculated free thyroxine. This may account for the erratic results of this calculation (Figure 2 places the thyroid in an unsteady state. It secretes iodine but cannot bind it. In normal subjects there is a large thyroid iodine pool, so it may be presumed that a few weeks exposure to methimazole will not produce major changes in the thyroid.
4) The changes in thyroidal iodide clearance seen were not consistent and hence are difficult to interpret. It should be noted that all of these clearances and the uptake values were within the normal range (12, 15 Other mechanisms for the effects noted during methyl testosterone administration could be mentioned. A direct effect on the pituitary to suppress its output of thyroid stimulating hormone is possible. The PBI would fall (as observed) but a marked fall in thyroid iodide clearance would also be expected (this was not observed). Furthermore, another mechanism to account for the increase in rate of degradation of thyroxine and fall in TBP would still be necessary. A direct effect on the thyroid to decrease secretion of thyroxine could explain the fall in PBI. If this mechanism were similar to the effect of iodine, there might be little change in thyroid iodide clearance. Nevertheless, the increased degradation of thyroxine and fall in TBP would still be unexplained. An effect similar to that produced by dinitrophenol, which increases the rate of metabolism of thyroxine and also suppresses the pituitary, is possible (16) . Usually a marked fall in thyroid iodide clearance is seen, however, and again the fall in TBP is not explained.
Therefore, although the theory presented, which proposes that the effects of methyl testosterone result from a primary alteration in TBP, is not proven, it seems the most likely working hypothesis at present.
It is of considerable interest that estrogenic hormones and pregnancy, which have been shown to produce a rise in PBI in serum, have an effect on thyroxine-binding of TBP which is opposite to that found with methyl testosterone (11, 14, 17, 18) . Detailed studies of other aspects of thyroid function during estrogen treatment in humans have not been reported.
The change in serum cholesterol cannot be directly inferred from this hypothesis, since, if anything, one would expect a fall in the level to correspond with the elevated free thyroxine level and utilization. An increase in serum cholesterol in male subjects with coronary artery disease and hypercholesterolemia when they were given methyl testosterone has been noted previously (19) . No data are available to suggest whether this effect is upon cholesterol synthesis or excretion, or whether it is direct or indirect.
It is possible that the exacerbation of hyperthyroidism observed by Kinsell and co-workers in patients receiving methyl testosterone might be explained by the fall in TBP and the consequent elevation of the level of free thyroxine. Since testosterone propionate did not produce such an exacerbation, it should prove valuable to determine whether testosterone propionate will affect thyroxine-binding by TBP.
SUM MARY
A study of the influence of methyl testosterone on human thyroid function is presented. The drug induced a striking fall in thyroxine-binding capacity of the thyroxine-binding alpha globulin of serum in all patients, and a less striking but consistent increase in the fractional rate of thyroxine disappearance from blood. Other findings were a slight fall in the serum protein-bound iodine, an increase in circulating free thyroxine, and an increase in the amount of thyroxine degraded per day. There were inconstant effects on the thyroidal and renal clearance of iodide. The hypothesis is offered that a fall in concentration of thyroxine-binding protein in serum is responsible for the changes observed. A consistent rise in serum cholesterol was also noted during the administration of methyl testosterone.
